Metastatic malignant neoplasm in the colon

Summary

Metastatic malignant neoplasm in the colon (MONDO:0041447) is a cancer and 1 clinical trial. A subtype of metastatic malignant neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	metastatic malignant neoplasm in the colon
Mondo ID	MONDO:0041447
NCIT	C8411
UMLS	C0346974
MedGen	83432
Is cancer (heuristic)	yes

Also known as: metastatic malignant neoplasm in the colon · metastatic malignant neoplasm to the colon · metastatic neoplasm to the colon · metastatic tumor to the colon · metastatic tumour to the colon

Disease family

This is a subtype of metastatic malignant neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › secondary malignant neoplasm › metastatic malignant neoplasm › metastatic malignant neoplasm in the colon

Related subtypes (6): metastatic carcinoma, metastasis from malignant tumor of colon, metastatic malignant neoplasm in the spinal cord, metastatic malignant neoplasm in the eye, neoplastic meningitis, metastatic malignant neoplasm in the brain

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
EARLY_PHASE1	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03164486	EARLY_PHASE1	ACTIVE_NOT_RECRUITING	First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide